Proteologics Ltd (Israel) Valuation

Proteologics Ltd recent Real Value cannot be determined due to lack of data. The prevailing price of Proteologics Ltd is 0.0. Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Macroaxis determines value of Proteologics Ltd from analyzing the company fundamentals such as Net Income of (1.44M), Return On Equity of (7.60)% and Shares Outstanding of 15.07M as well as examining its technical indicators and Probability Of Bankruptcy. In general, we support investing in undervalued entities and to dispose of overvalued entities since at some point stocks prices and their ongoing real values will merge together.
Horizon     30 Days    Login   to change

Proteologics Ltd Total Value Analysis

Proteologics Ltd is at this time anticipated to have takeover price of 2.57M with market capitalization of 904.48M, debt of 803K, and cash on hands of 8.67M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Proteologics Ltd fundamentals before making investing decisions based on the enterprise value of the company

Proteologics Ltd Asset Utilization

Proteologics Ltd holds negative application of asset of -5.63 pct., making only 0.06 for each of asset held by the company. Inadequate assets utilization implies the company is being less effective with each of asset it holds. In other words assets utilization of Proteologics Ltd shows how discouraging it operates for each spent on its asset.

Proteologics Ltd Profitability Analysis

The company reported revenue of . Net Loss for the year was (1.44M) with profit before overhead, payroll, taxes, and interest of 2M.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
See also Your Equity Center. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.